Live Breaking News & Updates on Anti Bacterial Agents

Stay updated with breaking news from Anti bacterial agents. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioVersys Extends its Series C Round to CHF 32.6 Million with Investment from the AMR Action Fund

BioVersys AG announces extension of its Series C investment round to CHF 32.6 million as the AMR Action Fund makes its first European-based investmentBASEL, Switzerland, January 05, 2023 / B3C newswire / BioVersys AG, a privately held clinical stage, multi-asset Swiss pharmaceutical company focusing on research a. ....

Marc Gitzinger , Carly Levine , Martin Heidecker , Eliane Schmidt , Seng Chin Mah , University Of Lille , Action Fund , Chief Executive Officer , Chief Investment Officer , Executive Assistant , Financial Management , Infectious Disease Medicine , Bacterial Infections , Anti Bacterial Agents , Critical Care , Drug Resistance , Cross Infection , Healthcare Associated Pneumonia , Pharmaceutical Preparations ,

ProtonDx's Dragonfly Diagnostic System Successfully Deployed at the 2022 Commonwealth Games

5-in-1 Respiratory Test Panel used to assess elite athletes LONDON, UK, August 31, 2022 / B3C newswire / Today, ProtonDx, a health technology company developing robust, point-of-need diagnostic solutions, announced that Dragonfly™, its portable, rapid diagnostic system, formed a key part of the diagnostic testing. ....

United Kingdom , City Of , Priya Kalia , Pantelis Georgiou , Niall Elliott , Jesus Rodriguez Manzano , Bob Enck , Test Panel , Team Scotland , Delivery Of Health Care , Imperial College London , Protondx Ltd , Biomedical Technology , Winter Games , Influenzab Virus , Respiratory Syncytial Virus , Human Rhinovirus , Chief Medical Officer , Olympic Winter , Professor Pantelis Georgiou , Assistant Professor Jesus Rodriguez Manzano , Lynne Trowbridge , Molecular Diagnostic Techniques , Respiratory Tract Infections , Nucleic Acids , Polymerase Chain Reaction ,

Accelerate Diagnostics Announces Commercialization in Europe of its Accelerate Arc™ System Having Co

Commercialization of the Accelerate Arc system, which includes the Accelerate Arc Module and BC kit, unlocks the path to automated, rapid microbial identification (ID) for positive blood cultures across the large installed base of MALDI system users. The Accelerate Arc system can cut hours of wait time, eliminate la. ....

Alexander Petti , Laura Pierson , John Meduri , Exchange Commission , European Congress , Delivery Of Health Care , Exchange Commission On , Diagnostics Inc , Accelerate Arc , Accelerate Arc Module , Accelerate Diagnostics , Clinical Microbiology , Infectious Diseases , Chief Strategy Officer , Accelerate Phenotest , Accelerate Pheno , Annual Report , Blood Culture , Matrix Assisted Laser Desorption Ionization , Bacteriological Techniques , Antimicrobial Stewardship , Hematologic Tests , Anti Bacterial Agents , Drug Resistance , Anti Infective Agents , Health Care ,

New Accelerate Pheno® Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID

New Accelerate Pheno® Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United States , Laura Pierson , European Congress , University Of Iowa , Allegheny Health , Exchange Commission , Delivery Of Health Care , Diagnostics Inc , University Of Arkansas , Blood Stream Infections , Associated With Reduction , Day Mortality , Data From Multicenter Study Highlight , Real World Clinical Utility , Diverse Healthcare Settings , Patient Populations , Accelerate Diagnostics , Improving Outcomes , Antibiotic Stewardship , Clinical Microbiology , Infectious Diseases , Accelerate Pheno , Bloodstream Infections , Quasi Experimental Multicenter Study , Poster Session , Study Experience ,

"Five-year resistance trends in pathogens causing healthcare-associated" by Abbas Al Mutair, Saad Alhumaid et al.

Abstract
Objectives: Awareness of antimicrobial resistance (AMR) patterns in a given healthcare setting is important to inform the selection of appropriate antimicrobial therapy to reduce the further rise and spread of AMR as well as the rate of healthcare-associated infections (HAIs) and multidrug-resistant (MDR) organisms. We aimed to describe resistance patterns to several antimicrobial agents in pathogens causing HAIs isolated from patients using data gathered at three private tertiary-care hospitals in Saudi Arabia. Methods: Data on trends in AMR among bacteria causing HAIs and MDR events in children and adults at three private hospitals were collected retrospectively (2015–2019) using surveillance data. Results: Over the 5-year period, 29 393 pathogens caused 17 539 HAIs in 15 259 patients. Approximately 57.3% of patients were female and the mean age was 38.4 ± 16.8 years (81.4% adults, 18.6% children). Gram-negative pathogens were four times more likely to cause HAIs ....

Saudi Arabia , Anti Bacterial Agents , Antimicrobial Resistance , Multidrug Resistance , Saudi Arabia , சவுதி அரேபியா , ஆடி அரேபியா ,